Ilse E.A. Hoffman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ilse E.A. Hoffman has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
E M Veys
Department of Rheumatology, Ghent University Hospital, Belgium
3 shared publicationsF De Keyser
Department of Rheumatology, Ghent University Hospital, Belgium
3 shared publicationsI Peene
Department of Rheumatology, Ghent University Hospital, Belgium
3 shared publications- David Alan Isenberg
Department of Ageing, Rheumatology and Regenerative Medicine, University College London , London
2 shared publications F Hulstaert
Innogenetics NV, Ghent, Belgium
2 shared publicationsK De Bosschere
Innogenetics NV, Ghent, Belgium
2 shared publications
Latest Publications
- Open Access
- 1 August 2005
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (8) , 1118-1119
Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis
Her medical history disclosed systemic polyarteritis nodosa (PAN) in 1991, at which time she presented with pain and swelling at the knees and ankles as well as cutaneous nodules over the medial side of the left ankle. This clinical presentation, together with the inflammatory biology, the absence of autoantibodies, the presence of radiological and scintigraphic periostitis, and the finding of microaneurysms upon arteriography, led to the diagnosis of PAN. She was successfully treated with corticosteroids over a period of 12 months. Upon discontinuation of the steroid treatment, she remained in remission.
- 1 August 2005
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (8) , 1118-1119
Open AccessCase number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis
Her medical history disclosed systemic polyarteritis nodosa (PAN) in 1991, at which time she presented with pain and swelling at the knees and ankles as well as cutaneous nodules over the medial side of the left ankle. This clinical presentation, together with the inflammatory biology, the absence of autoantibodies, the presence of radiological and scintigraphic periostitis, and the finding of microaneurysms upon arteriography, led to the diagnosis of PAN. She was successfully treated with corticosteroids over a period of 12 months. Upon discontinuation of the steroid treatment, she remained in remission.
- Open Access
- 1 February 2005
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (2) , 330-332
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
Two hundred and thirty five patients with SLE, meeting American College of Rheumatology (ACR) revised criteria for classification of SLE,7, 8 were prospectively included in four European centres. The study investigated associations between symptoms and specific antinuclear reactivities and has been reported elsewhere.9 Serum was available for further analysis in 201 patients. The male to female ratio was 25:176. The mean age was 40 years. The study was approved by the local ethics committees. Informed consent was obtained from all patients.
- 1 February 2005
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (2) , 330-332
Open AccessPresence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
Two hundred and thirty five patients with SLE, meeting American College of Rheumatology (ACR) revised criteria for classification of SLE,7, 8 were prospectively included in four European centres. The study investigated associations between symptoms and specific antinuclear reactivities and has been reported elsewhere.9 Serum was available for further analysis in 201 patients. The male to female ratio was 25:176. The mean age was 40 years. The study was approved by the local ethics committees. Informed consent was obtained from all patients.
- Open Access
- 1 January 2005
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (1) , 261-263
Diagnostic Performance and Predictive Value of Rheumatoid Factor, Anti-citrullinated Peptide Antibodies, and the HLA Shared Epitope for Diagnosis of Rheumatoid Arthritis
- 1 January 2005
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (1) , 261-263
Open AccessDiagnostic Performance and Predictive Value of Rheumatoid Factor, Anti-citrullinated Peptide Antibodies, and the HLA Shared Epitope for Diagnosis of Rheumatoid Arthritis
- Open Access
- 1 September 2004
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (9) , 1155-1158
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
Objectives: To study associations between antinuclear antibodies (ANA) and signs/symptoms in patients with systemic lupus erythematosus (SLE). Methods: A consecutive cohort of 289 patients with SLE was included; 235 fulfilled ACR criteria for SLE and were further analysed. ANA profiles were determined by line immunoassay and by indirect immunofluorescence on Crithidia luciliae. An extensive list of signs/symptoms was evaluated. Results: Five clusters of antibodies were defined by cluster analysis: 1—antibodies to SmB, SmD, RNP-A, RNP-C, and RNP-70k; 2—antibodies to Ro52, Ro60, and SSB; 3, 4, and 5—antibodies to ribosomal P, histones and dsDNA, respectively. Significant associations (p⩽0.01) were found between anti-RNP-70k, anti-RNP-A, anti-RNP-C and Raynaud’s phenomenon, between anti-RNP-A, anti-RNP-70k and leucopenia, and between anti-RNP-A, anti-RNP-C and a lower prevalence of urine cellular casts. Anti-SSA, anti-SSB were associated with xerostomia, and anti-SSB with pericarditis. Antibodies to ribosomal P were associated with haemolytic anaemia, leucopenia, and alopecia. Patients with anti-dsDNA antibodies had a higher risk for cellular casts and a lower risk for photosensitivity. Antihistone antibodies were associated with arthritis. Conclusions: In a large and consecutive cohort of patients with SLE, clusters of antibodies were identified. Previously reported associations of antibodies with symptoms were confirmed and new associations found.
- 1 September 2004
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (9) , 1155-1158
Open AccessSpecific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
Objectives: To study associations between antinuclear antibodies (ANA) and signs/symptoms in patients with systemic lupus erythematosus (SLE). Methods: A consecutive cohort of 289 patients with SLE was included; 235 fulfilled ACR criteria for SLE and were further analysed. ANA profiles were determined by line immunoassay and by indirect immunofluorescence on Crithidia luciliae. An extensive list of signs/symptoms was evaluated. Results: Five clusters of antibodies were defined by cluster analysis: 1—antibodies to SmB, SmD, RNP-A, RNP-C, and RNP-70k; 2—antibodies to Ro52, Ro60, and SSB; 3, 4, and 5—antibodies to ribosomal P, histones and dsDNA, respectively. Significant associations (p⩽0.01) were found between anti-RNP-70k, anti-RNP-A, anti-RNP-C and Raynaud’s phenomenon, between anti-RNP-A, anti-RNP-70k and leucopenia, and between anti-RNP-A, anti-RNP-C and a lower prevalence of urine cellular casts. Anti-SSA, anti-SSB were associated with xerostomia, and anti-SSB with pericarditis. Antibodies to ribosomal P were associated with haemolytic anaemia, leucopenia, and alopecia. Patients with anti-dsDNA antibodies had a higher risk for cellular casts and a lower risk for photosensitivity. Antihistone antibodies were associated with arthritis. Conclusions: In a large and consecutive cohort of patients with SLE, clusters of antibodies were identified. Previously reported associations of antibodies with symptoms were confirmed and new associations found.